Cresset Asset Management, LLC Poly Pid Ltd. Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
BUY
$8.4 - $9.99 $98,439 - $117,072
11,719 New
11,719 $106,000

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $59.2M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email